معرفی
Peter Bergman is a Professor of Clinical Immunology at Karolinska Institutet's Department of Laboratory Medicine since 2022, combining academic research with clinical work as a Senior Physician at Karolinska University Hospital. His research focuses on immune system dysfunction in infections, especially congenital immune defects. He earned his medical degree from Karolinska Institutet in 2001 and completed his PhD in 2005 on antimicrobial peptides and CNS infections. He became a specialist in clinical microbiology in 2013 and held a 6-year clinical research position from the Swedish Research Council. His roles include teaching in medical, dental, nursing, and biomedical programs, and他曾担任实验室医学系的基础教育负责人（2018-2022）。
Research interests include primary immunodeficiency, innate immunity, antimicrobial peptides, vitamin D's role in immunity, and vaccinology. His recent work explores SARS-CoV-2 impacts on immunocompromised patients and the efficacy of hyperbaric oxygen therapy. He has contributed to studies on TLR7 deficiency in severe COVID-19 cases and vitamin D's role in respiratory infections. His clinical work focuses on the immunodeficiency unit at Karolinska University Hospital's infectious disease clinic.
Key publications highlight vitamin D supplementation's effects on respiratory infections, MAIT cell biology, and outcomes of chronic lymphocytic leukemia patients during the pandemic. His work bridges basic science and clinical practice, addressing translational challenges in immunodeficiency and infection management.
